Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes : The MERLIN-TIMI 36 randomized trial. CommentaryMORROW, David A; SCIRICA, Benjamin M; NEWBY, L. Kristin et al.JAMA, the journal of the American Medical Association. 2007, Vol 297, Num 16, issn 0098-7484, 1775-1783,1823-1825 [12 p.]Article

Trial to evaluate the management of paroxysmal supraventricular tachycardia during an electrophysiology study with tecadenosonELLENBOGEN, Kenneth A; O'NEILL, Gearoid; PRYSTOWSKY, Eric N et al.Circulation (New York, N.Y.). 2005, Vol 111, Num 24, pp 3202-3208, issn 0009-7322, 7 p.Article

Effects of Ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: A randomized controlled trialCHAITMAN, Bernard R; PEPINE, Carl J; PARKER, John O et al.JAMA, the journal of the American Medical Association. 2004, Vol 291, Num 3, pp 309-316, issn 0098-7484, 8 p.Article

Termination of paroxysmal supraventricular tachycardia by Tecadenoson (CVT-510), a novel A₁-Adenosine receptor agonistPRYSTOWSKY, Eric N; NIAZI, Imran; FOGEL, Richard I et al.Journal of the American College of Cardiology. 2003, Vol 42, Num 6, pp 1098-1102, issn 0735-1097, 5 p.Article

Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man studyTEERLINK, John R; CLARKE, Cyril P; SCHILLER, Nelson B et al.Lancet (British edition). 2011, Vol 378, Num 9792, pp 667-675, issn 0140-6736, 9 p.Article

Metabolic approaches to the treatment of ischemic heart disease: The clinicians' perspective : Myocardial energy metabolism in heart failureWOLFF, Andrew A; ROTMENSCH, Heschi H; STANLEY, William C et al.Heart failure reviews. 2002, Vol 7, Num 2, pp 187-203, issn 1382-4147Article

The effects of the cardiac myosin activator, omecamtiv mecarbil, on cardiac function in systolic heart failure: a double-blind, placebo-controlled, crossover, dose-ranging phase 2 trialCLELAND, John G. F; TEERLINK, John R; SHABURISHVILI, Tamaz et al.Lancet (British edition). 2011, Vol 378, Num 9792, pp 676-683, issn 0140-6736, 8 p.Article

Comparative efficacy of ranolazine versus atenolol for chronic angina pectorisROUSSEAU, Michel F; POULEUR, Hubert; COCCO, Giuseppe et al.The American journal of cardiology. 2005, Vol 95, Num 3, pp 311-316, issn 0002-9149, 6 p.Article

Anti-ischemic effects and long-term survival during Ranolazine Monotherapy in Patients with chronic severe anginaCHAITMAN, Bernard R; SKETTINO, Sandra L; WOLFF, Andrew A et al.Journal of the American College of Cardiology. 2004, Vol 43, Num 8, pp 1375-1382, issn 0735-1097, 8 p.Article